Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

16.5K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.5K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

3.7K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.7K
Lampbrush Chromosomes01:51

Lampbrush Chromosomes

8.8K
In 1882, Flemming observed lampbrush chromosomes (LBC) in salamander eggs. Later in 1892, Rückert observed LBCs in shark egg cells and coined the term "lampbrush chromosomes" because they looked like brushes used to clean kerosene lamps.
LBCs are made up of two pairs of conjugating homologous chromatids. Each chromatid consists of alternatively positioned regions of condensed-inactive chromatin and loosely placed-active side loops, which can be contracted and extended. The loops...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-speed three-dimensional cross-sectional measurement of cultured neurons by scatterometry that improves resolution by an order of magnitude.

Optics express·2025
Same author

Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study.

International journal of hematology·2024
Same author

Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan.

The Journal of antimicrobial chemotherapy·2024
Same author

Comparison of pathophysiological differences in TAFRO syndrome with or without lymphadenopathy.

Journal of clinical and experimental hematopathology : JCEH·2024
Same author

Development of selective isolation media for detecting the genera Actinomyces and Schaalia from oral specimens containing indigenous bacteria.

Access microbiology·2024
Same author

Nationwide genome surveillance of carbapenem-resistant <i>Pseudomonas aeruginosa</i> in Japan.

Antimicrobial agents and chemotherapy·2024

Related Experiment Video

Updated: Mar 22, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.7K

[Chronic lymphocytic leukemia].

Sadao Aoki1

  • 1Department of Pathophysiology, Niigata University of Pharmacy and Applied Life Sciences.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|April 15, 2016
PubMed
Summary
This summary is machine-generated.

Novel drugs targeting the B-cell receptor (BCR) pathway, like ibrutinib and idelalisib, show high efficacy for chronic lymphocytic leukemia (CLL). These treatments, including BCL2 inhibitor ABT-199, offer mild toxicity but face regulatory delays in Japan.

More Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

8.2K
Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

12.3K

Related Experiment Videos

Last Updated: Mar 22, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.7K
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

8.2K
Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

12.3K

Area of Science:

  • Oncology
  • Pharmacology

Context:

  • Chronic lymphocytic leukemia (CLL) is a prevalent B-cell malignancy.
  • Novel targeted therapies are transforming CLL treatment paradigms.
  • Significant disparities exist in drug availability between Western countries and Japan.

Purpose:

  • To review the efficacy and safety of novel oral agents for chronic lymphocytic leukemia (CLL).
  • To highlight the potential of B-cell receptor (BCR) pathway inhibitors and BCL2 inhibitors in CLL management.
  • To address the unmet need for timely drug approval in Japan.

Summary:

  • Ibrutinib and idelalisib target the BCR pathway, demonstrating high efficacy in relapsed/refractory (RR) and treatment-naïve CLL, including cases with 17p deletion.
  • ABT-199, a BCL2 inhibitor, also shows significant efficacy in RR-CLL.
  • These novel agents exhibit favorable toxicity profiles, suitable for patients with poor performance status.

Impact:

  • These findings underscore the therapeutic potential of targeted agents in CLL.
  • The review emphasizes the need to expedite the approval of these life-saving medications in Japan.
  • Addressing the 'drug lag' is crucial for improving patient outcomes globally.